Please assess the completion status of the following clinical trial:

Trial Title: Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. STEMI~2. no prior treatment with statins~Exclusion Criteria:~1. age below 18 or above 81 years~2. unconscious patients~3. serum creatinine \> 176μmol/L~4. total-cholesterol \> 7.0 mmol/l~5. hypothyreoidism ((TSH \> 1.5 x ULN (upper limit of normal))~6. current liver disease (ALAT \> 2 x ULN)~7. unexplained creatine kinase \> 3 x ULN~8. alcohol or drug abuse within the last five years~9. prior myopathy or serious hypersensitivity reaction caused by statins~10. women with childbearing potential who were not using chemical or mechanical contraception~11. pregnant or breastfeeding women~12. history of malignancy unless a disease-free period of more than five years was present~13. patients with abnormal lung function test (LFT)~14. participation in another investigational drug study less than four weeks before enrolment in the present study~15. treatment with cyclosporine or fibrates.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 81 Years
- Healthy Volunteers: f

Study Arms:
- Rosuvastatin 5mg/day (Type: ACTIVE_COMPARATOR): Rosuvastatin 5mg/day
- Rosuvastatin 40mg/day (Type: ACTIVE_COMPARATOR): Rosuvastatin 40mg/day

Based on this trial design, predict the completion outcome and termination type (if applicable).